What is Immuneering Corp - Ordinary Shares Class A Annual Net Profit?

Immuneering Corp - Ordinary Shares Class A Annual Net Profit fell 14.15% in the last year to $61.04 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Immuneering Corp - Ordinary Shares Class A Price to Earning Ratio?

Immuneering Corp - Ordinary Shares Class A Price to Earning Ratio is -0.84, which is negative.

What is Immuneering Corp - Ordinary Shares Class A Stock Price?

Immuneering Corp - Ordinary Shares Class A Stock Price fell 5.84% and underperformed its sector by 17.39% in the past year.

What is Immuneering Corp - Ordinary Shares Class A Quarterly Net profit?

Immuneering Corp - Ordinary Shares Class A Quarterly Net profit fell 5.16% YoY to $15.05 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Immuneering Corp - Ordinary Shares Class A Debt to Equity Ratio?

Immuneering Corp - Ordinary Shares Class A Debt to Equity Ratio of 0.1 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Immuneering Corp - Ordinary Shares Class A Return on Equity(ROE)?

Immuneering Corp - Ordinary Shares Class A Return on Equity(ROE) for the last financial year was -92.51%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Immuneering Corp - Ordinary Shares Class A Mutual Fund Holding?

Immuneering Corp - Ordinary Shares Class A Mutual Fund Holding decreased by 0.39% in the last quarter to 7.24.

What is Immuneering Corp - Ordinary Shares Class A Institutional Holding?

Immuneering Corp - Ordinary Shares Class A Institutional Holding decreased by 0.33% in the last quarter to 11.67.

Immuneering Corp - Ordinary Shares Class A XNAS: IMRX

Immuneering Corp - Ordinary Shares Class A Live Share Price Today, Share Analysis and Chart

Name: Immuneering Corp - Ordinary Shares Class A: Is Infosys Ltd. worth buying?
Item: Immuneering Corp - Ordinary Shares Class A
Rating: 1.43408325
Author: Trendlyne DVM scores

about

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

1.45 -0.03 (-2.03%)

62.14% Fall from 52W High

117.5K XNAS Volume

XNAS 22 May, 2025 4:05 PM (EDT)

Not Eligible

-

Expensive Valuation

9.8 / 100

Technically Neutral

47.5 / 100

No estimates available

Immuneering Corp - Ordinar... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Immuneering Corp - Ordinary Shares Class A FAQ

How is Immuneering Corp - Ordinary Shares Class A today?

Immuneering Corp - Ordinary Shares Class A today is trading in the red, and is down by -2.03% at 1.45.

How has Immuneering Corp - Ordinary Shares Class A performed historically?

Immuneering Corp - Ordinary Shares Class A is currently trading down -2.03% on an intraday basis. In the past week the stock rose 15.08%. stock has been down -17.61% in the past quarter and fell -5.84% in the past year. You can view this in the overview section.